Gastrointestinal Stromal Tumor (GIST) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors Interventions: Drug: Ripretinib; Drug: binimetinib Sponsor: Deciphera Pharmaceuticals LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2021 Category: Research Source Type: clinical trials
